12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

  • STATUS
    Not Recruiting
  • sponsor
    Crescendo
Updated on 3 September 2021

Summary

12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

Description

Adults with Rheumatoid Arthritis with inadequate response to MTX may qualify to have Vectra DA guided treatment for 12 months.

Details
Condition Rheumatoid Arthritis
Clinical Study IdentifierTX147736
SponsorCrescendo
Last Modified on3 September 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note